Business

Strategic Partnership for Chinese Market Expansion

Strategic Partnership for Chinese Market Expansion.

articleCambridge Cognition Holdings PlcNovember 24, 20223/company/cambridge-cognition-holdings-plc/news/strategic-partnership-for-chinese-market-expansion
Strategic Partnership for Chinese Market Expansion

About this update from Cambridge Cognition Holdings Plc

[{"type":"text","content":"\n \n \n \n  \n \n \n \n \n Cambridge Cognition Holdings Plc\n \n \n \n \n (\"\n \n \n Cambridge Cognition\"\n \n \n or the \"Company\")\n \n \n \n \n  \n \n \n \n \n Strategic Partnership for Chinese Market Expansion\n \n \n \n \n  \n \n \n \n Cambridge Cognition Holdings Plc (AIM: COG), which develops and markets digital solutions to assess brain health, is pleased to announce an expansion in the Chinese market through a strategic partnership with Luca Healthcare Limited (\"Luca Healthcare\"), a category leader in digital screening, treatment and management tools in China.  Cambridge Cognition has signed an exclusive licencing agreement with Luca Healthcare to commercialise the Company's suite of leading cognitive assessment tools in China for both the pharmaceutical and healthcare markets.\n \n \n  \n \n \n The strategic partnership provides Cambridge Cognition with an efficient and low risk geographic expansion whilst leveraging the Company's recent projects to go live in an Amazon Web Service (\"AWS\") data centre in China and implement a range of Chinese languages.  Cambridge Cognition will be paid through a mix of milestone payments and royalties.  As well as a commercial license, the partnership includes the opportunity to collaborate on co-developments to improve both companies' solutions. \n \n \n  \n \n \n China is the second most active clinical trial market in the world after the US, having hosted nearly 10,000 industry sponsored trials in the last five years with 14% being in Central Nervous System conditions1. The healthcare market opportunity in China for cognitive impairment diagnostics may also be considerable with nearly 40 million people affected by mild cognitive impairment and nearly 10 million living with Alzheimer's disease2.\n \n \n  \n \n \n Cambridge Cognition has been laying the groundwork to successfully capitalise on this significant market opportunity since 2019 by establishing a dedicated service in the region delivered from a secure cloud infrastructure provided by AWS in China; developing task variants in the most common spoken (Cantonese and Mandarin) and written (Chinese simplified) languages; and building on an existing relationship with one of the leading Chinese universities, Fudan University, Shanghai.\n \n \n \n  \n \n \n \n \n Matthe...

More updates from Cambridge Cognition Holdings Plc